SCHEMBL2859570

SCHEMBL2859570

CC(C)[C@H](C)NC(=O)c1ccnc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 1/20 0.50
FAP Q12884 1/20 0.50
TAS1R3 Q7RTX0 3/20 0.49
TAS1R1 Q7RTX1 3/20 0.49
TAS1R2 Q8TE23 3/20 0.49
FDPS P14324 1/20 0.45
CYP2C9 P11712 3/20 0.43
ROCK2 O75116 2/20 0.43
PRKACA P17612 2/20 0.43
PRKACG P22612 2/20 0.43
PRKACB P22694 2/20 0.43
AKT1 P31749 2/20 0.43
PRKG1 Q13976 2/20 0.43
ROCK1 Q13464 1/20 0.43
FOLH1 Q04609 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
NAMPT P43490 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13702150 0.87 FDPS (0.57) PREPFAPTAS1R3TAS1R1TAS1R2
SCHEMBL24571697 0.82 FDPS (0.43) FDPSMEN1LMNAMAPK1KMT2A
SCHEMBL24567563 0.82 FDPS (0.43) FDPSMEN1LMNAMAPK1KMT2A
SCHEMBL24568629 0.81 PREP (0.50) PREPFAPTAS1R3TAS1R1TAS1R2
SCHEMBL2856403 0.81 PREP (0.50) PREPFAPTAS1R3TAS1R1TAS1R2
SCHEMBL2856039 0.81 PREP (0.50) PREPFAPTAS1R3TAS1R1TAS1R2
SCHEMBL25029288 0.81 LMNA (0.52) FDPSMEN1LMNAMAPK1KMT2A
SCHEMBL2877347 0.80 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2CYP2C9NAMPT
SCHEMBL2866110 0.80 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2CYP2C9NAMPT
SCHEMBL2859970 0.80 PREP (0.55) PREPFAPTAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
EP-2174931-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME Sumitomo Chemical Company, Limited (JP) 2010-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137376-A1 AMIDE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME NAAA, NAT1, SAT1 PREP 617/4885FAP 4212/4885TAS1R3 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.